Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non–Cross-Resistant Schedule PURPOSE: Platinum-based ...
Hosted on MSN
AstraZeneca’s New Phase IIIb Study: Capivasertib and Fulvestrant for Advanced Breast Cancer
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Phase I/IIa Study of Cisplatin and Gemcitabine As Induction Chemotherapy Followed by Concurrent Chemoradiotherapy With Gemcitabine and Paclitaxel for Locally Advanced Non–Small-Cell Lung Cancer ...
Novartis has reported positive outcomes from the multi-centre Phase IIIB APPULSE-PNH study of oral Fabhalta (iptacopan) in adults with paroxysmal nocturnal haemoglobinuria (PNH). These findings are ...
Eli Lilly's EBGLYSS has demonstrated improvement in skin condition and itch relief in patients with moderate-to-severe atopic dermatitis, according to new results from the Phase IIIb ADapt study.
Add Yahoo as a preferred source to see more of our stories on Google. The double-blind Incyte has announced results from the Phase IIIb TRuE-AD4 trial of Opzelura (ruxolitinib cream) for adults with ...
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset ...
(RTTNews) - HUTCHMED (China) Limited (HCM) announced positive results from the SAVANNAH Phase II trial, which showed high and durable response rates with the combination of savolitinib and TAGRISSO in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results